Original Research

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

Lammerich A, Bias P, Gertz B

International Journal of Women's Health 2015, 7:707-716

Published Date: 16 July 2015